Pleno Inc.
3 known investors
Pleno develops a genomic testing instrument platform designed to make multiomics testing faster, lower-cost, and higher-plex than existing methods like NGS, PCR, and microarrays. It targets clinical genomics applications such as oncology to support AI-driven precision medicine.
Investors · 3
Competitors · 3
by search overlapNeoGenomics7 shared keywordsNeoGenomics develops diagnostic tests and tools for cancer care, including tests for immunotherapy response monitoring, therapy selection, and minimal residual disease detection.
ZAGENO5 shared keywords
Labcorp4 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Companies competing with Pleno Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Pleno Inc. do?
- Pleno develops a genomic testing instrument platform designed to make multiomics testing faster, lower-cost, and higher-plex than existing methods like NGS, PCR, and microarrays. It targets clinical genomics applications such as oncology to support AI-driven precision medicine.
- Who are Pleno Inc.'s investors?
- Pleno Inc.'s investors include Foresite Capital, Medical Excellence Capital, Deerfield Management Company.